What's breaking now, across thousands of outlets.
Key PointsJohnson & Johnson’s medtech business is experiencing turbulence, but the company has what it takes to overcome it.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
The mortgage REIT posted a 16.9% tangible book-value drop in Q3, yet management projects 18-20% returns on new investments, today, Oct. 20, 2026.
At an event in London, Hodgson told attendees, “critical minerals are no longer simply industrial commodities,” the Financial Post reported.
Malawi's annual inflation eased to 19.4% in September, its lowest since May 2022, but non-food prices are still rising at 31.5% a year.
A rare multifamily agency license positions Zions to capture fee income competitors cannot, reshaping its long-term earnings mix.
Margin expansion and near-record commercial lending suggest the bank's acquisition strategy is translating into tangible operating gains.
Data science and disciplined credit management are protecting profitability as the bank expands market share.